Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Privacy policy
Data selected by Name eurican
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Eurican DAP - V/MRP/16/0007 MERIAL S.A.S., Francija QI07AD02 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine Distemper virus, strain BA5,Canine Adenovirus type 2, strain DK13,Canine Parvovirus type 2, strain CAG2
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Merial., Francija
Date of authorisation/renewal: 31-Mar-2016
Marketing authorisation valid until: 30-Mar-2021
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 191216LI (22-Dec-2016)
Labelling text: [PDF] 191216M (22-Dec-2016)
Summary of product characteristics: [PDF] 191216ZA (22-Dec-2016)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/MRP/16/0007-01 10 Stikla flakons, 1 deva No information -
V/MRP/16/0007-02 50 Stikla flakons, 1 deva No information -
Eurican DAPPi - V/MRP/16/0008 MERIAL S.A.S., Francija QI07AD04 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine Distemper virus, strain BA5,Canine Adenovirus type 2, strain DK13,Canine Parvovirus type 2, strain CAG2,Canine Parainfluenza virus type 2, strain CGF 2004/75
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Merial., Francija
Date of authorisation/renewal: 31-Mar-2016
Marketing authorisation valid until: 30-Mar-2021
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300316LI (31-Mar-2016)
Labelling text: [PDF] 300316M (31-Mar-2016)
Summary of product characteristics: [PDF] 300316ZA (31-Mar-2016)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/MRP/16/0008-01 10 Stikla flakons, 1 deva No information -
V/MRP/16/0008-02 50 Stikla flakons, 1 deva No information -
V/MRP/16/0008-03 100 Stikla flakons, 1 deva No information -
Eurican DAPPi-LR - V/NRP/02/1415 MERIAL S.A.S., Francija QI07AJ06 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Attenuated canine distemper virus,Attenuated parainfluenza type 2 virus,Inactivated Leptospira icterohaemorrhagiae,Inactivated Leptospira canicola,Inactivated Rabies virus,Live attenuated canine adenovirus (CAV2),Live attenuated Canine Parvovirus (CPV)
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 12-Apr-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 300916LI (04-Oct-2016)
Labelling text: [PDF] 300916M (04-Oct-2016)
Summary of product characteristics: [PDF] 300916ZA (04-Oct-2016)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/NRP/02/1415-01 10 Stikla flakons, 1 deva Available [JPG] [JPG]
V/NRP/02/1415-02 50 Stikla flakons, 1 deva No information -
Eurican DAP-LR - V/NRP/95/0197 MERIAL S.A.S., Francija QI07AI03 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Attenuated canine distemper virus,Inactivated Leptospira icterohaemorrhagiae,Inactivated Leptospira canicola,Inactivated Rabies virus,Live attenuated canine adenovirus (CAV2),Live attenuated Canine Parvovirus (CPV)
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 27-May-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 210819LI (21-Aug-2019)
Labelling text: [PDF] 210819M (21-Aug-2019)
Summary of product characteristics: [PDF] 210819ZA (21-Aug-2019)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/NRP/95/0197-01 10 Stikla flakons, 1 deva Available [JPG] [JPG] [JPG] [JPG] [JPG] [JPG] [PDF] [JPG] [JPG]
V/NRP/95/0197-02 50 Stikla pudelīte, 1 deva No information [PDF]
Eurican DAPPi-L - V/NRP/02/1414 MERIAL S.A.S., Francija QI07AI02 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Attenuated canine distemper virus,Attenuated parainfluenza type 2 virus,Inactivated Leptospira icterohaemorrhagiae,Inactivated Leptospira canicola,Live attenuated canine adenovirus (CAV2),Live attenuated Canine Parvovirus (CPV)
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 12-Apr-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 240719LI (24-Jul-2019)
Labelling text: [PDF] 240719M (24-Jul-2019)
Summary of product characteristics: [PDF] 240719ZA (24-Jul-2019)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/NRP/02/1414-01 10 Stikla flakons, 1 deva Available [JPG] [JPG]
V/NRP/02/1414-02 50 Stikla flakons, 1 deva No information -
Eurican DAP-Lmulti - V/DCP/15/0044 MERIAL S.A.S., Francija QI07AI03 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Inactivated Leptospira interrogans serogroup Canicola, strain 16070,Inactivated Leptospira interrogans serogroup Icterohaemorrhagiae, strain 16069,Canine Distemper virus, strain BA5,Canine Adenovirus type 2, strain DK13,Canine Parvovirus type 2, strain CAG2,Inactivated Leptospira interrogans serogroup and serovar Grippotyphosa strain Grippo Mal 1540
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes , Francija
Date of authorisation/renewal: 29-Sep-2015
Marketing authorisation valid until: 28-Sep-2020
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 281217LI (03-Jan-2018)
Labelling text: [PDF] 281217M (03-Jan-2018)
Summary of product characteristics: [PDF] 281217ZA (03-Jan-2018)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/DCP/15/0044-01 10 Stikla pudele, 1 deva No information -
V/DCP/15/0044-02 25 Stikla pudele, 1 deva No information -
V/DCP/15/0044-03 50 Stikla pudele, 1 deva No information -
Eurican DAPPi-Lmulti - V/DCP/15/0045 MERIAL S.A.S., Francija QI07AI02 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and suspension for suspension for injection
International name (active substance): Inactivated Leptospira interrogans serogroup Canicola, strain 16070,Inactivated Leptospira interrogans serogroup Icterohaemorrhagiae, strain 16069,Canine Distemper virus, strain BA5,Canine Adenovirus type 2, strain DK13,Canine Parvovirus type 2, strain CAG2,Canine Parainfluenza virus type 2, strain CGF 2004/75,Inactivated Leptospira interrogans serogroup and serovar Grippotyphosa strain Grippo Mal 1540
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes , Francija
Date of authorisation/renewal: 29-Sep-2015
Marketing authorisation valid until: 28-Sep-2020
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 281217LI (03-Jan-2018)
Labelling text: [PDF] 281217M (03-Jan-2018)
Summary of product characteristics: [PDF] 281217ZA (03-Jan-2018)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/DCP/15/0045-01 10 Stikla pudele, 1 deva Available -
V/DCP/15/0045-02 25 Stikla pudele, 1 deva No information -
V/DCP/15/0045-03 50 Stikla pudele, 1 deva No information -
Eurican Lmulti - V/DCP/15/0046 MERIAL S.A.S., Francija QI07AB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Leptospira interrogans serogroup Canicola, strain 16070,Inactivated Leptospira interrogans serogroup Icterohaemorrhagiae, strain 16069,Inactivated Leptospira interrogans serogroup and serovar Grippotyphosa strain Grippo Mal 1540
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes , Francija
Date of authorisation/renewal: 29-Sep-2015
Marketing authorisation valid until: 28-Sep-2020
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 281217LI (03-Jan-2018)
Labelling text: [PDF] 281217M (03-Jan-2018)
Summary of product characteristics: [PDF] 281217ZA (03-Jan-2018)
Availability of medicinal product: No information

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
V/DCP/15/0046-01 10 Stikla flakons, 1 deva No information -
V/DCP/15/0046-02 25 Stikla flakons, 1 deva No information -
V/DCP/15/0046-03 50 Stikla flakons, 1 deva No information -
Eurican Herpes 205 - EU/2/01/029/002 MERIAL S.A.S., Francija QI07AA06 dogs Vairāk

Medicinal product information

Pharmaceutical form: powder and solvent for emulsion for injection
International name (active substance): Canine herpesvirus antigen
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 18-Apr-2006
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
Availability of medicinal product: No information
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
EU/2/01/029/002 2 Stikla pudelīte, 50 deva No information -
Eurican Herpes 205 - EU/2/01/029/001 MERIAL S.A.S., Francija QI07AA06 dogs Vairāk

Medicinal product information

Pharmaceutical form: powder and solvent for emulsion for injection
International name (active substance): Canine herpesvirus antigen
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 18-Apr-2006
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
Availability of medicinal product: Available
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
EU/2/01/029/001 2 Stikla pudelīte, 10 deva Available -
Eurican Herpes 205 - EU/2/01/029/003 MERIAL S.A.S., Francija QI07AA06 dogs Vairāk

Medicinal product information

Pharmaceutical form: powder and solvent for emulsion for injection
International name (active substance): Canine herpesvirus antigen
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 18-Apr-2006
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
Availability of medicinal product: Available
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Availability of medicinal product Labelling
EU/2/01/029/003 2 Stikla pudelīte, 1 deva Available -

11 records · Download

  • 1